Literature DB >> 21554925

T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.

Sandra T A van Bijnen1, Marian Withaar, Frank Preijers, Arnold van der Meer, Theo de Witte, Petra Muus, Harry Dolstra.   

Abstract

OBJECTIVE: To investigate the presence of T cells with natural killer cell receptors (NKR) in paroxysmal nocturnal hemoglobinuria (PNH), and their potential involvement in clonal expansion of glycosylphosphatidylinositol (GPI)-deficient hematopoietic stem cells by selective immune attack to normal and not GPI-deficient hematopoietic stem cells.
MATERIALS AND METHODS: By flow cytometry, the frequency and number of T cells expressing NKR was evaluated in 39 PNH patients and compared to healthy controls. Elevated T cell subsets in PNH were assessed for differential cytotoxic lysis of GPI(+) and GPI(-) CD34(+) hematopoietic progenitor cell lines.
RESULTS: In PNH patients, the frequency (p < 0.001) and absolute number of T cells expressing the NKR CD56 (p = 0.01) were significantly increased. Furthermore, a higher percentage of T cells expressed the activating NKR NKG2D (p < 0.01), NKG2C (p < 0.01), and KIR2DS4 (p = 0.01). Further characterization showed that these populations predominantly consist of CD8(+) effector memory CD45RA(+) T cells (T(EMRA)). NKR(+) cytotoxic T-lymphocyte lines isolated from PNH patient peripheral blood and bone marrow displayed high cytotoxicity towards CD34(+) hematopoietic progenitor cell lines and K562 cells, suggesting major histocompatibility complex class I-independent cytotoxicity. These cytotoxic T lymphocyte (CTL) lines are capable of differential lysis of GPI(+) and GPI(-) hematopoietic cell lines, however, not in all cases. This suggests that multiple factors, such as the highly activated status of in vitro cultured CTLs, influence whether GPI-dependent lysis occurs.
CONCLUSIONS: The increased frequency of CD8(+) effector-memory T cells with activating NKR and cytotoxicity toward hematopoietic cell lines suggests involvement in bone marrow failure and clonal expansion in PNH.
Copyright © 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554925     DOI: 10.1016/j.exphem.2011.04.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  4 in total

1.  T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.

Authors:  Kohei Hosokawa; Sachiko Kajigaya; Keyvan Keyvanfar; Wangmin Qiao; Yanling Xie; Danielle M Townsley; Xingmin Feng; Neal S Young
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 2.  Clinical significance of acquired somatic mutations in aplastic anaemia.

Authors:  J C W Marsh; G J Mufti
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

3.  Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria.

Authors:  Nathaniel Mon Père; Tom Lenaerts; Jorge M Pacheco; David Dingli
Journal:  PLoS Comput Biol       Date:  2018-06-18       Impact factor: 4.475

4.  Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Camille Lobry; Ashish Bains; Leah B Zamechek; Sherif Ibrahim; Iannis Aifantis; David J Araten
Journal:  Exp Hematol Oncol       Date:  2019-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.